Supremacie

Label at a glance#

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENTS: ENSULIZOLE 2.0%, HOMOSALATE 2.0%, OCTINOXATE 7.0%, OXYBENZONE 4.0%.

WARNINGS SECTION

WARNINGS: For external use only. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if irritation develops and lasts.

INDICATIONS & USAGE SECTION

USES: Sun Protection Factor 15. Helps prevent sunburn.

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS: Apply evenly before sun exposure and as needed.

PRINCIPAL DISPLAY PANEL - 50 g jar

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

L'BEL
PARIS

SUPREMACIE NX JOUR

traitement reconstituant crème
de jour pour le visage fps 15
tratamiento reconstituyente crema
facial de día fps 15
replenishing treatment daytime face
cream spf 15

peau normale à sèche / normal to dry
skin / cutis normal a seco

50 g e (1.7 oz.)

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

• Supremacie NX Jour
• Ensulizole, Homosalate, Octinoxate, and Oxybenzone
• Ensulizole
• Homosalate
• Octinoxate
• Oxybenzone

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.